Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Seifritz

26 indexed publications match this author name.

ORCID: 0000-0002-7311-4426
OpenAlex: https://openalex.org/A5045362944

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 16 Brain Imaging 13 Mechanism of Action 12 Emotional Processing 11 Aging 9 Depression 7 Clinical Trial 6 Chronic Pain 5 Randomized Controlled Trial 5 Default Mode Network 4 Consciousness 4 Healthy Volunteers 4

Journals

Biological Psychiatry 4 European Neuropsychopharmacology 3 Universität Zürich, ZORA 2 Psychopharmacology 2 Research Square 1 medRxiv 1 iScience 1 Scientific Reports 1

Publication history

Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational StudyResearch Square · 2025-12-09 Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatUniversität Zürich, ZORA · 2025-09-28 Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation RetreatmedRxiv · 2025-07-29 595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08 Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31 The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18 Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Unknown journal · 2024-04-22 Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25 Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and MeditationBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2023-07-16 Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.Unknown journal · 2023-01-29 Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27 Psychedelics in the treatment of unipolar and bipolar depression.Unknown journal · 2022-07-04 Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12 Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-08-31 Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24 LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07 Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30 Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17 The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21 Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31 P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24 Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25 Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15 The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26 Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09 Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25

Author directory